Cheng and colleagues [28] provided supporting evidence for this phenomenon, showing that L1CAM was highly expressed in a population of glioblastoma stem cells in the invasive fronts of primary GBMs, and targeted L1CAM might reduce GBM cancer invasion and tumor recurrence. This evidence concerns the gene L1CAM and neoplasm.